drugset / Trial / NCT04018339
A Study of RTA 402 in Obese Adults
RandomizedParallel-groupSingle-blindOther
Summary
To investigate changes in body weight and body composition in obese adults after repeated oral administration of RTA 402 once daily for 16 weeks, using placebo as a control.
Timeline
- Start
- 2019-08-20
- Primary completion
- 2020-05-28
- Completion
- 2020-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bardoxolone methyl | Small molecule | 5 mg | Oral |
| Subject | Bardoxolone methyl | Small molecule | 10 mg | Oral |